中国CHANCE研究写入美国《缺血性脑血管病二级预防指南》

2014-06-09 田栋梁 医学界杂志

导语:今年5月1日,美国发布的新版《缺血性脑卒中二级预防指南》中正式引用了CHANCE研究,王拥军说:“这是第一次中国研究改写美国指南。” 2014年5月1日,美国发布的最新版《缺血性脑血管病二级预防指南》中首次描述了我国首都医科大学附属北京天坛医院脑血管病中心进行的CHANCE研究结果,随着这一国际脑卒中领域最权威、影响力最大的指南的改写,全球的指南都将改变。CHANCE研究详细见:NEJ

导语:今年5月1日,美国发布的新版《缺血性脑卒中二级预防指南》中正式引用了CHANCE研究,王拥军说:“这是第一次中国研究改写美国指南。”

2014年5月1日,美国发布的最新版《缺血性脑血管病二级预防指南》中首次描述了我国首都医科大学附属北京天坛医院脑血管病中心进行的CHANCE研究结果,随着这一国际脑卒中领域最权威、影响力最大的指南的改写,全球的指南都将改变。CHANCE研究详细见:NEJM:王拥军教授发现“双抗”显著降低卒中再发风险(CHANCE研究)


北京天坛医院于2010年10月29日成立了天坛脑血管病中心。每年的那一天是世界卒中日,选择那一天是在宣布要与世界卒中研究同步前进。在那之前和之后,北京天坛医院在国内外的神经内科领域均取得了卓越成就,而所有这些成就都与一个人有关:副院长王拥军。

最年轻的科主任



38岁那年,王拥军空降到北京天坛医院,成为天坛医院神经内科历史上最年轻的科主任。在这之前,王拥军是北京市科技新星培养计划被选中的一员,在美国阿肯色医科大学进行生化方面的博士后研究。

在美国,王拥军参与了一系列世界前沿研究,并以突出的表现成为实验室总管。通过在美国的学习,王拥军领悟到:建立一个系统比学一个方法,对国家、 对个人更重要。

这个时候,天坛医院正计划打造世界一流的神经内科,院长戴建平拨通了远在美国的王拥军的电话,两个人聊了一个小时,王拥军决定回国到天坛医院去。他说:“我一直想做脑血管病的体系建设,戴院长给了我充分空间,他说科室设计由你自己做,医院全力配合你的工作需要,这是吸引我的最重要因素。”

中国每12秒就有一人发生脑卒中,每21秒就有一人死于脑卒中,而脑卒中的抢救是一个多学科协作过程。进入天坛医院工作的王拥军终于可以实践他“建立一个系统比学习一种方法更重要”的理念了。

第一家标准卒中单元

王拥军在天坛医院致力于打造中国神经内科新模式的第一项成就,是创建了国内第一家标准卒中单元,戴院长践行了全力配合王拥军工作需要的承诺,把医院里的一层楼按照王拥军的想法进行改建,并受到了社科委的资金支持。

2001年5月,王拥军亲自规划设计的中国第一个卒中单元在天坛医院诞生,从根本上创新了脑卒中的诊治模式,在病人早期治疗时,结合康复训练,形成了新的病房管理模式,为病人提供集医疗、康复、预防、宣教为一体的身心共治综合医疗模式。

这一模式建成后,天坛医院脑卒中患者的死亡率降低了15%,致残率下降了30%,医疗费用降低20%。这一模式向全国推广后,不仅提升了国内脑血管病的整体治疗水平,也大大拉近了中国和国际的距离。

这只是王拥军宏伟规划的第一步,距离他打造与国际同步的高级卒中中心,还有漫长的道路。

全球最大样本库

为了让中国的卒中中心跻身全球脑血管病研究的核心之列,王拥军开始筹划打造世界上最大的脑血管病样本库。

2009年,脑卒中病因与发病机制分型样本库在天坛医院启动,这个样本库吸引了国内外的专家前来共同开发使用样本库数据。同时天坛卒中临床试验与临床研究中心还开发出首个临床试验与研究一体的标准化临床数据与标本采集系统,在国际上同样也是一项创新。

国家“重大新药创制”科技重大专项实施管理办公室也把重大疾病临床评价基地之一的脑血管病新药项目交给了王拥军带领的天坛团队负责。王拥军表示:“我们可以承担世界上任何国家、满足任何国家新药审批所需要的临床研究。”

CHANCE研究(Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events,氯吡格雷用于急性非致残性脑血管事件高危人群的疗效研究)是王拥军副院长承担设计的大型多中心、随机、双盲临床试验,由国内17个省市114家医疗机构历时5年共同合作完成。该研究成功证实了氯吡格雷合并阿司匹林的治疗方案将使得轻型脑血管病患者复发为致残致死的严重脑血管病几率减少为32%,能为我国每年至少减少10万例再发卒中,以每例卒中病人入院治疗费用2.5万元计算,可使得我国每年至少节约直接入院费用25亿元。

王拥军院长说:“CHANCE的中文意思是机会,起这个名字意味着这一研究对中国是个机会,对中国脑血管病人也是一个提高生存质量的机会。”CHANCE研究结束时,英国正在做相关研究,他们看到中国的研究结果后,直接中断了自己的研究,认为中国的CHANCE研究已经解决了这个问题,他们不需要再做了。

今年5月1日,美国发布的新版《缺血性脑卒中二级预防指南》中正式引用了CHANCE研究,王拥军说:“这是第一次中国研究改写美国指南。”

打造国际高级卒中中心

2010年,天坛脑血管病中心成立,目标是做成研究型中心,力争打造成国际高级卒中中心。

神经内科医生杜万良介绍:“天坛脑血管病中心不是一个实体,而是一个大的协作中心,是多学科合作部门,包括神经内科、神经外科、神经介入、神经放射、神经影像、集合卒中门诊、脑血管病抢救治疗、卒中培训、医疗质量控制多功能于一体,开展临床、临床试验、流行病学、实验室多层次研究。”

王拥军表示:“研究型中心有三个重要标志:每个病人都纳入研究,每个医生都从事研究,这两点天坛医院都做到了,唯一没做到的是研究经费超过临床产值。”去年天坛脑血管病中心135张床,临床收入2.5亿元,研究经费不到1亿元,王拥军表示:这个比例相差还很悬殊。

但王拥军带领的天坛脑血管病中心团队正在大步向目标迈进,在某些领域已经走在了国际前列。王拥军说:“在过去三年,我们中心在STROKE杂志发表的文章连续三年都是国际单中心第一,国际上没有第二家医院能够做到三年在这个杂志发表18篇论文。”

王拥军说:“优秀的企业总是制造概念,好的资源总是来自于整合。很多时候,体系比技术更重要。急诊资源的整合使我们有了绿色通道,病房资源的整合使我们有了卒中单元,整个医院资源的整合使我们有了卒中中心。我们生活在一个比以往任何时候都强调协作的时代。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
    2014-06-11 chendoc247
  6. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
    2014-06-11 chendoc247
  7. [GetPortalCommentsPageByObjectIdResponse(id=1806988, encodeId=da94180698829, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Tue Dec 02 19:10:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644411, encodeId=fdb716444115c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Jun 12 10:10:00 CST 2014, time=2014-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892612, encodeId=d4b71892612eb, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Dec 07 04:10:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374067, encodeId=ba3113e4067eb, content=<a href='/topic/show?id=d98be93867d' target=_blank style='color:#2F92EE;'>#缺血性脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79386, encryptionId=d98be93867d, topicName=缺血性脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=682d366, createdName=yangwen5709, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558257, encodeId=52f8155825e6d, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564266, encodeId=f7d4156426606, content=<a href='/topic/show?id=c99f45e9dc' target=_blank style='color:#2F92EE;'>#CHANCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4579, encryptionId=c99f45e9dc, topicName=CHANCE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daed14955633, createdName=chendoc247, createdTime=Wed Jun 11 13:10:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9777, encodeId=6b149e771c, content=年轻有为~, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa9590666, createdName=pullo, createdTime=Tue Jun 10 18:00:00 CST 2014, time=2014-06-10, status=1, ipAttribution=)]
    2014-06-10 pullo

    年轻有为~

    0

相关资讯

Diabetologia:糖尿病患者的发生卒中风险的性别差异

很多大血管事件都存在性别差异,如卒中等。但糖尿病患者中卒中发生情况并不清楚。研究者前瞻性选择了10876位男性和19278位女性糖尿病患者,比较它们的糖化血红蛋白水平以及卒中的差异。通过6.7年的随访观察,2949例患者发生了卒中,多元回归分析校正发现,不同基线水平的HbA(1c)存在差异。以HbA(1c) 6.0-6.9% [42-52 mmol/mol]为参考组,<6.0%,7.0-7.

马长生:心房颤动的卒中、出血及风险评分CHA2DS2VASC

心房颤动(房颤)是临床上最常见的心律失常之一。同正常人群相比,房颤具有很高的致死率和致残率,血栓栓塞并发症是其致残、致死的主要原因。非瓣膜性房颤患者的卒中风险是正常人的 5~6倍,年发生率约为5%。因此,预防卒中对房颤患者尤为重要。口服抗凝药是目前预防房颤血栓栓塞并发症最有效的方法,调整剂量的华法林可使房颤卒中的相对危险降低68%,优于单用或双联抗血小板治疗。真实世界研究荟萃同时表明,华法林显

Stroke:卒中患者长期预后情况跟踪报道

卒中是全球范围内的一种高致死、致残率疾病,是国际医疗卫生界面临的严峻挑战之一。卒中患者神经系统受损从而导致功能性残疾,需他人护理。研究发现卒中患者生活质量明显下降,与患者年龄、情绪、神经功能损害程度、尿失禁和认知功能密切相关。我们可关注卒中患者长期预后情况,从而优化医疗保健计划并减轻卒中的疾病负担。 然而,关于卒中患者长期预后的研究较少(≥10年)。来自瑞典隆德大学的Iwarsson博士等学

JAMA:急救车溶栓治疗的评估

卒中是致死致残的主要疾病之一。在急性缺血性卒中时,一旦经脑成像排除脑出血后,使用组织性纤溶酶原激活剂(tPA)进行溶栓是主要的治疗选择。溶栓时间对急性缺血性卒中的预后至关重要。 在脑卒中时,神经元快速死亡,并且随机安慰剂对照试验显示tPA有时间依赖性效果:越早用于治疗(90min以内),预后越好。然而,只有少数卒中患者接受tPA溶栓治疗,并且根据欧洲卒中登记情况显示,这少数人中只有11%的患

Stroke:SSRIs可能使出血性卒中恶化

一项丹麦研究显示,卒中发生前使用选择性5-羟色胺再摄取抑制剂(SSRIs)可能使部分患者事件恶化。 在出血性卒中患者中,症状出现前90天内使用1种SSRI与严重卒中(OR 1.41,95%CI:1.08~1.84)和30天内死亡(OR 1.60,95%CI:1.17~2.18)风险增加有关。然而,在缺血性卒中患者中,SSRIs使用与任何预后均无关。研究者为Janne Kaergaard Mort

左心耳与房颤脑卒中预测的研究进展

摘要:脑卒中是房颤的主要危害之一,目前研究显示造成脑卒中的房颤血栓大多来源于左心耳。而左心耳与房颤脑卒中的关系,目前受到越来越多的关注。相关研究提示,左心耳的解剖形态、大小、容积、流速与脑卒中之间存在着联系。 关键词:左心耳;房颤;脑卒中 脑卒中是房颤的主要危害之一,目前研究显示造成房颤脑卒中的血栓大多来源于左心耳[1-3]。左心耳(LAA)因为其特殊的解剖结构、功能特点,成为房颤脑卒中的